Prospective Biomarkers of Bone Metabolism in Hemophilia A

NCT02306694 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

16

Enrollment

OTHER

Sponsor class

Conditions

Hemophilia
Bone Disease

Interventions

DRUG: Advate

Sponsor

Oregon Health and Science University

Collaborators

[object Object]